Inhibidores de la tirosina quinasa de bruton

COMPUESTOS HETEROCÍCLICOS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON; COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE; Y SU USO PARA LA PREVENCIÓN O TRATAMIENTO DE TUMORES DE LA SANDRE Y DEL SISTEMA LINFÁTICO, ENFERMEDADES AUTOINMUNITARIAS E INFLAMATORIAS, ENTRE OTRAS ENFERMEDADES. The present inv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SMIRNOVA, Svetlana Sergeevna, GORBUNOVA, Svetlana Leonidovna, SILONOV, Sergey Aleksandrovich, KOZHEMYAKINA, Natalia Vladimirovna, MIKHAYLOV, Leonid Evgen`evich, IAKOVLEV, Pavel Andreevich, POPKOVA, Aleksandra Vladimirovna, KUSHAKOVA, Anna Sergeevna, MOLDAVSKY, Alexander, GAVRILOV, Aleksey Sergeevich, ALESHUNIN, Pavel Aleksandrovich, REKHARSKY, Mikhail Vladimirovich, KUKUSHKINA, Anna Aleksandrovna
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:COMPUESTOS HETEROCÍCLICOS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON; COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE; Y SU USO PARA LA PREVENCIÓN O TRATAMIENTO DE TUMORES DE LA SANDRE Y DEL SISTEMA LINFÁTICO, ENFERMEDADES AUTOINMUNITARIAS E INFLAMATORIAS, ENTRE OTRAS ENFERMEDADES. The present invention relates to a new compound of formula I: or pharmaceutically acceptable salt, solvate or stereoisomer thereof, wherein: V1 is C or N, V2 is C(R2) or N, whereby if V1 is C then V2 is N, if V1 is C then V2 is C(R2), or if V1 is N then V2 is C(R2); each n, k is independently 0, 1; each R2, R11 is independently H, D, Hal, CN, NR'R", C(O)NR'R", C1-C6 alkoxy; R3 is H, D, hydroxy, C(O)C1-C6 alkyl, C(O)C2-C6 alkenyl, C(O)C2-C6 alkynyl, C1-C6 alkyl; R4 is H, Hal, CN, CONR'R", hydroxy, C1-C6 alkyl, C1-C6 alkoxy; L is CH2, NH, O or chemical bond; R1 is selected from the group of the fragments, comprising: Fragment 1, Fragment 2, Fragment 3 each A1, A2, A3, A4 is independently CH, N, CHal; each A5, A6, A7, A8, A9 is independently C, CH or N; R5 is H, CN, Hal, CONR'R", C1-C6 alkyl, non-substituted or substituted by one or more halogens; each R' and R" is independently selected from the group, comprising H, C1-C6 alkyl, C1-C6 cycloalkyl, aryl; R6 is selected from the group: [formula II] each R7, R8, R9, R10 is independently vinyl, methylacetylenyl; Hal is CI, Br, I, F, which have properties of inhibitor of Bruton's tyrosine kinase (Btk), to pharmaceutical compositions containing such compounds, and their use as pharmaceuticals for treatment of diseases and disorder.